Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

PMN310 is a humanized monoclonal antibody (mAb) designed and developed to selectively target only soluble amyloid-beta ...

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...

In an exceptionally rare case, a patient with a high genetic risk of developing Alzheimer's appears to have avoided his ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer ...

A growing body of research suggests that infections, including those caused by common bacteria in gum disease, could ...

Recent research links Alzheimer's disease to bacterial gum infections, specifically the pathogen Porphyromonas gingivalis.

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

In recent years, a growing number of scientific studies have backed an alarming hypothesis: Alzheimer's disease isn't just a ...